My HPRA: Register

PIU letters sent to healthcare professionals can be found below

Tegretol - Product Range (PA0896/030/001-006)
Pfizer - Solu-Medrone 40mg and 125mg: New Prescribing Information
Azzalure, - CRN2198923 (CRN008LD2)
Curium Life Forward - Ultra-Technekow FM, 2.15-43.00 GBq, radionuclide generator
GlaxoSmithKline - Amoxil Vials 500 mg, powder for solution for injection or infusion, PA 1077/33/4
Johnson & Johnson Miconazole (Daktarin) 20 mg/g oral gel: co-administration with warfarin now contraindicated except when Daktarin oral gel is specifically prescribed and used under medical supervision with close monitoring of INR

Solu-Medrone information update HCP -Nov 2017

Glucohage update - June 2016
Product Information Update for Amoxil - GSK - April 2017
Innohep 10,000 IU/ml Vial and Syringes - Leo Pharma 15.03.2017
Sanofi, update of warning relating the risk in patients with ischaemic heart disease.
Levonorgestrel-containing medicines for emergency hormonal contraception 13.12.2016
HPRA notice for Levonorgestrel 13.12.2016
Innohep 20,000 IU/ml Vial and Syringes - Leo Pharma 15.11.2016
Videx PIU letter 23.05.2016
BCH letters 16.03.16
Orap letter 25.02.2016
Decapeptyl letter
Targocid letter
Zinnat letter
Caverject letter
Sublimaze letter
Sinemet Tablets & Sinemet Plus Tablets Letter

Important information regarding cookies and the HPRA

By using this website, you consent to the use of cookies in accordance with the HPRA Cookie Policy.
For more information on cookies, see our cookie policy.

Click here to accept the cookie policy and hide this message